Management of malignant lymphomas.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000145:classification / Q000401:mortality / Q000473:pathology / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000145:classification / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D011344:Procarbazine / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D014748:Vinca Alkaloids; D011344:Procarbazine